A giant cell tumour of bone presented in the os sacrum of a prepubertal girl. Surgery with reconstruction was performed, but total resection was impossible. Zoledronate failed to avoid tumour regrowth, and treatment was changed to denosumab, despite not being recommended for use in growing children. Denosumab treatment for 21 months reduced and stabilized tumour size, the girl became pain free with asymptomatic side effects as mild hypocalcemia, hypophosphatemia and sclerosis of newly formed bone.
Keywords: Bone markers; Bone specific alkaline phosphatase; Denosumab; Giant cell tumour of bone; Os sacrum; Prepubertal; Zoledronate.
© 2023 The Authors. Published by Elsevier Inc.